These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 11740432)
1. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Marian AJ; Salek L; Lutucuta S Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432 [TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis for hypertrophic cardiomyopathy. Marian AJ; Roberts R J Mol Cell Cardiol; 2001 Apr; 33(4):655-70. PubMed ID: 11273720 [TBL] [Abstract][Full Text] [Related]
3. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury. Marian AJ; Roberts R Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880 [TBL] [Abstract][Full Text] [Related]
4. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661 [TBL] [Abstract][Full Text] [Related]
5. Modifier genes for hypertrophic cardiomyopathy. Marian AJ Curr Opin Cardiol; 2002 May; 17(3):242-52. PubMed ID: 12015473 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121 [TBL] [Abstract][Full Text] [Related]
7. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605 [TBL] [Abstract][Full Text] [Related]
8. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]
9. Aetiology and pathogenesis of hypertrophic cardiomyopathy. Lombardi R; Betocchi S Acta Paediatr Suppl; 2002; 91(439):10-4. PubMed ID: 12572836 [TBL] [Abstract][Full Text] [Related]
10. Novel locus for an inherited cardiomyopathy maps to chromosome 7. Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466 [TBL] [Abstract][Full Text] [Related]
11. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Marian AJ; Braunwald E Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181 [TBL] [Abstract][Full Text] [Related]
12. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice. Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503 [TBL] [Abstract][Full Text] [Related]
14. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239 [TBL] [Abstract][Full Text] [Related]
15. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period. Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315 [TBL] [Abstract][Full Text] [Related]
16. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy. Bottillo I; D'Angelantonio D; Caputo V; Paiardini A; Lipari M; De Bernardo C; Giannarelli D; Pizzuti A; Majore S; Castori M; Zachara E; Re F; Grammatico P Gene; 2016 Feb; 577(2):227-35. PubMed ID: 26656175 [TBL] [Abstract][Full Text] [Related]
18. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739 [TBL] [Abstract][Full Text] [Related]